CCL2 expression was lower in most tumors relative to normal tissues, which may stem from differences in the degree of immune infiltration of tumors such that monocyte and macrophage chemotaxis was not achieved to the same extent in all cancer types. The gene discussed is CCL2; the disease is cancer.